Penile squamous cell carcinoma
Clinical trials for Penile squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Penile squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Penile squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a targeted drug shrink advanced penile cancer when chemotherapy stops working?
Disease control Not yet recruitingThis Phase 2 trial tests amivantamab, a targeted drug given as a shot under the skin, in adults with advanced penile cancer that has spread or returned after at least one round of platinum-based chemotherapy. The study includes two groups based on HPV status and measures how many…
Matched conditions: PENILE SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Antibody-Drug conjugate aims to hit Hard-to-Treat penile cancer
Disease control Not yet recruitingPenile squamous cell carcinoma is a rare and aggressive cancer with limited options once it progresses after platinum-based chemotherapy. This phase 2 trial tests sacituzumab tirumotecan, an antibody-drug conjugate that targets the TROP-2 protein on cancer cells, in about 37 part…
Matched conditions: PENILE SQUAMOUS CELL CARCINOMA
Phase 2 • Sponsor: Latin American Cooperative Oncology Group • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC